ALN-SOD

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-SOD, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS) [Phase 1, Phase 2]

See pricing